USFDA asks Philips Respironics to notify patients about ventilator recall
"Taking this action today enables the FDA to mandate that Philips Respironics improve its communication about the recall and the serious risk posed by the foam used in the recalled products with patients," the regulator added.
New Delhi: The U.S. Food and Drug Administration (FDA) asked Dutch medical equipment maker Philips Respironics on Thursday to notify patients about the company's recall of certain ventilators and other breathing assistance machines in June last year.FDA said in a statement that it had determined the order necessary, citing the risk of harm posed by the recalled products.Read Also -...
New Delhi: The U.S. Food and Drug Administration (FDA) asked Dutch medical equipment maker Philips Respironics on Thursday to notify patients about the company's recall of certain ventilators and other breathing assistance machines in June last year.
Read Also - Philips expanded ventilator recall classified as most serious by USFDA
Philips invasive and noninvasive ventilators support the needs of the patient and care providers from hospital through the home. Our solutions are designed to deliver the highest possible clinical and patient experience. The final goal of our partnership is to help care providers and health systems as they navigate complex and changing patient conditions and care settings when treating respiratory insufficiency.
Read Also - Philips, USFDA in talks post new ventilator findings
Disclaimer: This site is primarily intended for healthcare professionals. Any content/information on this website does not replace the advice of medical and/or health professionals and should not be construed as medical/diagnostic advice/endorsement/treatment or prescription. Use of this site is subject to our terms of use, privacy policy, advertisement policy. © 2024 Minerva Medical Treatment Pvt Ltd